Cargando…
Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide)
The aim of this research was to test the efficacy and potential clinical application of intranasal administration of galanin-like peptide (GALP) as an anti-obesity treatment under the hypothesis that GALP prevents obesity in mice fed a high-fat diet (HFD). Focusing on the mechanism of regulation of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648535/ https://www.ncbi.nlm.nih.gov/pubmed/37958806 http://dx.doi.org/10.3390/ijms242115825 |
_version_ | 1785135361658191872 |
---|---|
author | Takenoya, Fumiko Shibato, Junko Yamashita, Michio Kimura, Ai Hirako, Satoshi Chiba, Yoshihiko Nonaka, Naoko Shioda, Seiji Rakwal, Randeep |
author_facet | Takenoya, Fumiko Shibato, Junko Yamashita, Michio Kimura, Ai Hirako, Satoshi Chiba, Yoshihiko Nonaka, Naoko Shioda, Seiji Rakwal, Randeep |
author_sort | Takenoya, Fumiko |
collection | PubMed |
description | The aim of this research was to test the efficacy and potential clinical application of intranasal administration of galanin-like peptide (GALP) as an anti-obesity treatment under the hypothesis that GALP prevents obesity in mice fed a high-fat diet (HFD). Focusing on the mechanism of regulation of lipid metabolism in peripheral tissues via the autonomic nervous system, we confirmed that, compared with a control (saline), intranasally administered GALP prevented further body weight gain in diet-induced obesity (DIO) mice with continued access to an HFD. Using an omics-based approach, we identified several genes and metabolites in the liver tissue of DIO mice that were altered by the administration of intranasal GALP. We used whole-genome DNA microarray and metabolomics analyses to determine the anti-obesity effects of intranasal GALP in DIO mice fed an HFD. Transcriptomic profiling revealed the upregulation of flavin-containing dimethylaniline monooxygenase 3 (Fmo3), metallothionein 1 and 2 (Mt1 and Mt2, respectively), and the Aldh1a3, Defa3, and Defa20 genes. Analysis using the DAVID tool showed that intranasal GALP enhanced gene expression related to fatty acid elongation and unsaturated fatty acid synthesis and downregulated gene expression related to lipid and cholesterol synthesis, fat absorption, bile uptake, and excretion. Metabolite analysis revealed increased levels of coenzyme Q10 and oleoylethanolamide in the liver tissue, increased levels of deoxycholic acid (DCA) and taurocholic acid (TCA) in the bile acids, increased levels of taurochenodeoxycholic acid (TCDCA), and decreased levels of ursodeoxycholic acid (UDCA). In conclusion, intranasal GALP administration alleviated weight gain in obese mice fed an HFD via mechanisms involving antioxidant, anti-inflammatory, and fatty acid metabolism effects and genetic alterations. The gene expression data are publicly available at NCBI GSE243376. |
format | Online Article Text |
id | pubmed-10648535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106485352023-10-31 Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide) Takenoya, Fumiko Shibato, Junko Yamashita, Michio Kimura, Ai Hirako, Satoshi Chiba, Yoshihiko Nonaka, Naoko Shioda, Seiji Rakwal, Randeep Int J Mol Sci Article The aim of this research was to test the efficacy and potential clinical application of intranasal administration of galanin-like peptide (GALP) as an anti-obesity treatment under the hypothesis that GALP prevents obesity in mice fed a high-fat diet (HFD). Focusing on the mechanism of regulation of lipid metabolism in peripheral tissues via the autonomic nervous system, we confirmed that, compared with a control (saline), intranasally administered GALP prevented further body weight gain in diet-induced obesity (DIO) mice with continued access to an HFD. Using an omics-based approach, we identified several genes and metabolites in the liver tissue of DIO mice that were altered by the administration of intranasal GALP. We used whole-genome DNA microarray and metabolomics analyses to determine the anti-obesity effects of intranasal GALP in DIO mice fed an HFD. Transcriptomic profiling revealed the upregulation of flavin-containing dimethylaniline monooxygenase 3 (Fmo3), metallothionein 1 and 2 (Mt1 and Mt2, respectively), and the Aldh1a3, Defa3, and Defa20 genes. Analysis using the DAVID tool showed that intranasal GALP enhanced gene expression related to fatty acid elongation and unsaturated fatty acid synthesis and downregulated gene expression related to lipid and cholesterol synthesis, fat absorption, bile uptake, and excretion. Metabolite analysis revealed increased levels of coenzyme Q10 and oleoylethanolamide in the liver tissue, increased levels of deoxycholic acid (DCA) and taurocholic acid (TCA) in the bile acids, increased levels of taurochenodeoxycholic acid (TCDCA), and decreased levels of ursodeoxycholic acid (UDCA). In conclusion, intranasal GALP administration alleviated weight gain in obese mice fed an HFD via mechanisms involving antioxidant, anti-inflammatory, and fatty acid metabolism effects and genetic alterations. The gene expression data are publicly available at NCBI GSE243376. MDPI 2023-10-31 /pmc/articles/PMC10648535/ /pubmed/37958806 http://dx.doi.org/10.3390/ijms242115825 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Takenoya, Fumiko Shibato, Junko Yamashita, Michio Kimura, Ai Hirako, Satoshi Chiba, Yoshihiko Nonaka, Naoko Shioda, Seiji Rakwal, Randeep Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide) |
title | Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide) |
title_full | Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide) |
title_fullStr | Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide) |
title_full_unstemmed | Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide) |
title_short | Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide) |
title_sort | transcriptomic (dna microarray) and metabolome (lc-tof-ms) analyses of the liver in high-fat diet mice after intranasal administration of galp (galanin-like peptide) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648535/ https://www.ncbi.nlm.nih.gov/pubmed/37958806 http://dx.doi.org/10.3390/ijms242115825 |
work_keys_str_mv | AT takenoyafumiko transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide AT shibatojunko transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide AT yamashitamichio transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide AT kimuraai transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide AT hirakosatoshi transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide AT chibayoshihiko transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide AT nonakanaoko transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide AT shiodaseiji transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide AT rakwalrandeep transcriptomicdnamicroarrayandmetabolomelctofmsanalysesoftheliverinhighfatdietmiceafterintranasaladministrationofgalpgalaninlikepeptide |